论文部分内容阅读
目的 探讨肿瘤相关物质群 ( TSGF)与醛缩酶 ( AL D)的检测在原发性肝癌 ( PL C)介入治疗中的价值。方法 检测治疗前及治疗后患者血清 TSGF和 AL D含量。结果 TSGF和 AL D含量变化在介入治疗前后显著差异 ( P<0 .0 5 )。结论 原发性肝癌介入治疗前后动态观察 TSGF和 AL D含量变化 ,对疗效评价及预后判断有意义。
Objective To investigate the value of tumor related substances (TSGF) and aldolase (ALD) in the interventional treatment of primary liver cancer (PL C). Methods The levels of serum TSGF and ALD in patients before and after treatment were measured. Results The changes of TSGF and ALD contents were significantly different before and after interventional treatment (P <0.05). Conclusion The dynamic changes of TSGF and ALD in patients with primary liver cancer before and after interventional therapy are significant to evaluate the curative effect and prognosis.